Tracking contrast agents using real-time 2D photoacoustic imaging system for cardiac applications

Author(s):  
Ragnar Olafsson ◽  
Leonardo Montilla ◽  
Pier Ingram ◽  
Russell S. Witte
The Prostate ◽  
2015 ◽  
Vol 76 (3) ◽  
pp. 307-315 ◽  
Author(s):  
Akio Horiguchi ◽  
Kazuhiro Tsujita ◽  
Kaku Irisawa ◽  
Tadashi Kasamatsu ◽  
Kazuhiro Hirota ◽  
...  

2013 ◽  
Author(s):  
Andrew Heinmiller ◽  
Kimberly Homan ◽  
Stanislav Emelianov ◽  
Adam Cole ◽  
Sanjiv Gambhir ◽  
...  

2020 ◽  
Vol 245 (4) ◽  
pp. 321-329 ◽  
Author(s):  
Jeesu Kim ◽  
Eun-Yeong Park ◽  
Byullee Park ◽  
Wonseok Choi ◽  
Ki J Lee ◽  
...  

Photoacoustic imaging is a non-invasive and non-ionizing biomedical technique that has been investigated widely for various clinical applications. By taking the advantages of conventional ultrasound imaging, hand-held operation with a linear array transducer should be favorable for successful clinical translation of photoacoustic imaging. In this paper, we present new key updates contributed to the previously developed real-time clinical photoacoustic and ultrasound imaging system for improving the clinical usability of the system. We developed a seamless image optimization platform, designed a real-time parameter control software with a user-friendly graphical user interface, performed Monte Carlo simulation of the optical fluence in the imaging plane, and optimized the geometry of the imaging probe. The updated system allows optimizing of all imaging parameters while continuously acquiring the photoacoustic and ultrasound images in real-time. The updated system has great potential to be used in a variety of clinical applications such as assessing the malignancy of thyroid cancer, breast cancer, and melanoma. Impact statement Photoacoustic imaging is a promising biomedical imaging modality that can visualize both structural and functional information of biological tissue. Because of its easiness to be integrated with conventional ultrasound imaging systems, numerous studies have been conducted to develop and apply clinical photoacoustic imaging systems. However, most of the systems were not suitable for general-purpose clinical applications due to one of the following reasons: target specific design, immobility, inaccessible operation sequence, and lack of hand-held operation. This study demonstrates a real-time clinical photoacoustic and ultrasound imaging system, which can overcome the limitations of the previous systems for successful clinical translation.


Author(s):  
Ryo Nagaoka ◽  
Takuya Tabata ◽  
Ryo Takagi ◽  
Shin Yoshizawa ◽  
Shin-Ichiro Umemura ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Soorya James ◽  
Kai Neuhaus ◽  
Mary Murphy ◽  
Martin Leahy

AbstractWith the advent of stem cell therapy for spinal cord injuries, stroke, burns, macular degeneration, heart diseases, diabetes, rheumatoid arthritis and osteoarthritis; the need to track the survival, migration pathways, spatial destination and differentiation of transplanted stem cells in a clinical setting has gained increased relevance. Indeed, getting regulatory approval to use these therapies in the clinic depends on biodistribution studies. Although optoacoustic imaging (OAI) or photoacoustic imaging can detect functional information of cell activities in real-time, the selection and application of suitable contrast agents is essential to achieve optimal sensitivity and contrast for sensing at clinically relevant depths and can even provide information about molecular activity. This review explores OAI methodologies in conjunction with the specific application of exogenous contrast agents in comparison to other imaging modalities and describes the properties of exogenous contrast agents for quantitative and qualitative monitoring of stem cells. Specific characteristics such as biocompatibility, the absorption coefficient, and surface functionalization are compared and how the labelling efficiency translates to both short and long-term visualization of mesenchymal stem cells is explored. An overview of novel properties of recently developed optoacoustic contrast agents and their capability to detect disease and recovery progression in clinical settings is provided which includes newly developed exogenous contrast agents to monitor stem cells in real-time for multimodal sensing.


2016 ◽  
Vol 53 (7) ◽  
pp. 071701
Author(s):  
张宇 Zhang Yu ◽  
薛月菊 Xue Yueju ◽  
贾金亮 Jia Jinliang ◽  
金晓勇 Jin Xiaoyong ◽  
刘洪山 Liu Hongshan ◽  
...  

2014 ◽  
Vol 19 (8) ◽  
pp. 086013 ◽  
Author(s):  
Taiichiro Ida ◽  
Yasushi Kawaguchi ◽  
Satoko Kawauchi ◽  
Keiichi Iwaya ◽  
Hitoshi Tsuda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document